Author： Olivieri Ignazio D'Angelo Salvatore Palazzi Carlo Lubrano Ennio Leccese Pietro
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.3, 2010-09, pp. : 399-414
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging drugs for rheumatoid arthritis
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. :
Access to resources
Recommend
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. :
Emerging drugs to treat juvenile idiopathic arthritis
By Ruperto Nicolino Martini Alberto
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :
Adalimumab: In Psoriatic Arthritis
By Simpson Dene Scott Lesley J.
Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. :
Economic Burden of Psoriatic Arthritis
By Ackermann Christoph Kavanaugh Arthur
PharmacoEconomics, Vol. 26, Iss. 2, 2008-01 ,pp. :